Oaktree Acquisition Corp. III Life Sciences (OACC)
Nasdaq: OACC · Blank Checks · Los Angeles, CA · filing with the SEC since 2024
Filings
53 filings since 2017 beside 13 insider forms · and emerging growth company · read from EDGAR on Nov 13, 2026Due next and emerging growth company
10-Q
Quarterly report for the quarter ending Sep 30, 2026Non-accelerated filers and smaller reporting companies have 45 days after the quarter ends; quarter ends are taken to the month end.
by Nov 14, 2026
10-K
Annual report for the fiscal year ending Dec 31, 2026Non-accelerated filers and smaller reporting companies have 90 days after the fiscal year ends.
by Mar 31, 2027
A deadline is the latest date the SEC's rules allow for its filer category. It is not a forecast of the day the company files. The proxy statement was last filed Oct 2, 2026.
Filings a yearinsider forms included
311916
2026 counts to Nov 13, 2026.
Officer or director change (8-K item 5.02): 4 times in the last 36 months, the newest Oct 29, 2025.SEC letters: 7 in the last 36 months, the newest Oct 21, 2024.
Insider forms (3, 4, 5 and 144) are counted each year but not listed here; the people and their trades are on the Ownership tab.
FiledFormWhat it is, in plain wordsPeriodAsk
Oct 26, 2026
8-K items 3.02, 5.03, 5.07, 9.01
Shares sold without registration; Charter, bylaw or fiscal-year change; Shareholder vote · Current report
Oct 23, 2026
Nov 5, 2024
8-K items 3.02, 8.01, 9.01
Shares sold without registration; Other event · Current report
Oct 30, 2024
Oct 25, 2024
8-K items 1.01, 3.02, 5.03, 8.01, 9.01
Major agreement signed; Shares sold without registration; Charter, bylaw or fiscal-year change; Other event · Current report
Oct 23, 2024
40 of 53 shown
Every row opens the filing on EDGAR. The plain words are the site's own for each form and each 8-K item; the complete history, insider forms included, is on EDGAR.